367 related articles for article (PubMed ID: 28943253)
1. IAP-Based Cell Sorting Results in Homogeneous Transplantable Dopaminergic Precursor Cells Derived from Human Pluripotent Stem Cells.
Lehnen D; Barral S; Cardoso T; Grealish S; Heuer A; Smiyakin A; Kirkeby A; Kollet J; Cremer H; Parmar M; Bosio A; Knöbel S
Stem Cell Reports; 2017 Oct; 9(4):1207-1220. PubMed ID: 28943253
[TBL] [Abstract][Full Text] [Related]
2. FolR1: a novel cell surface marker for isolating midbrain dopamine neural progenitors and nascent dopamine neurons.
Gennet N; Tamburini C; Nan X; Li M
Sci Rep; 2016 Sep; 6():32488. PubMed ID: 27580818
[TBL] [Abstract][Full Text] [Related]
3. Identification of transplantable dopamine neuron precursors at different stages of midbrain neurogenesis.
Jönsson ME; Ono Y; Björklund A; Thompson LH
Exp Neurol; 2009 Sep; 219(1):341-54. PubMed ID: 19555687
[TBL] [Abstract][Full Text] [Related]
4. Differences in neurogenic potential in floor plate cells along an anteroposterior location: midbrain dopaminergic neurons originate from mesencephalic floor plate cells.
Ono Y; Nakatani T; Sakamoto Y; Mizuhara E; Minaki Y; Kumai M; Hamaguchi A; Nishimura M; Inoue Y; Hayashi H; Takahashi J; Imai T
Development; 2007 Sep; 134(17):3213-25. PubMed ID: 17670789
[TBL] [Abstract][Full Text] [Related]
5. Identifying the optimal developmental age of human pluripotent stem cell-derived midbrain dopaminergic progenitors for transplantation in a rodent model of Parkinson's disease.
de Luzy IR; Pavan C; Moriarty N; Hunt CPJ; Vandenhoven Z; Khanna A; Niclis JC; Gantner CW; Thompson LH; Parish CL
Exp Neurol; 2022 Dec; 358():114219. PubMed ID: 36055392
[TBL] [Abstract][Full Text] [Related]
6. Transcriptome analysis reveals transmembrane targets on transplantable midbrain dopamine progenitors.
Bye CR; Jönsson ME; Björklund A; Parish CL; Thompson LH
Proc Natl Acad Sci U S A; 2015 Apr; 112(15):E1946-55. PubMed ID: 25775569
[TBL] [Abstract][Full Text] [Related]
7. Isolation of human induced pluripotent stem cell-derived dopaminergic progenitors by cell sorting for successful transplantation.
Doi D; Samata B; Katsukawa M; Kikuchi T; Morizane A; Ono Y; Sekiguchi K; Nakagawa M; Parmar M; Takahashi J
Stem Cell Reports; 2014 Mar; 2(3):337-50. PubMed ID: 24672756
[TBL] [Abstract][Full Text] [Related]
8. Isolation of LMX1a Ventral Midbrain Progenitors Improves the Safety and Predictability of Human Pluripotent Stem Cell-Derived Neural Transplants in Parkinsonian Disease.
de Luzy IR; Niclis JC; Gantner CW; Kauhausen JA; Hunt CPJ; Ermine C; Pouton CW; Thompson LH; Parish CL
J Neurosci; 2019 Nov; 39(48):9521-9531. PubMed ID: 31641054
[TBL] [Abstract][Full Text] [Related]
9. Engraftable Induced Pluripotent Stem Cell-Derived Neural Precursors for Brain Repair.
Zygogianni O; Kouroupi G; Taoufik E; Matsas R
Methods Mol Biol; 2020; 2155():23-39. PubMed ID: 32474865
[TBL] [Abstract][Full Text] [Related]
10. Improved cell therapy protocols for Parkinson's disease based on differentiation efficiency and safety of hESC-, hiPSC-, and non-human primate iPSC-derived dopaminergic neurons.
Sundberg M; Bogetofte H; Lawson T; Jansson J; Smith G; Astradsson A; Moore M; Osborn T; Cooper O; Spealman R; Hallett P; Isacson O
Stem Cells; 2013 Aug; 31(8):1548-62. PubMed ID: 23666606
[TBL] [Abstract][Full Text] [Related]
11. Efficiently Specified Ventral Midbrain Dopamine Neurons from Human Pluripotent Stem Cells Under Xeno-Free Conditions Restore Motor Deficits in Parkinsonian Rodents.
Niclis JC; Gantner CW; Alsanie WF; McDougall SJ; Bye CR; Elefanty AG; Stanley EG; Haynes JM; Pouton CW; Thompson LH; Parish CL
Stem Cells Transl Med; 2017 Mar; 6(3):937-948. PubMed ID: 28297587
[TBL] [Abstract][Full Text] [Related]
12. Enhanced production of mesencephalic dopaminergic neurons from lineage-restricted human undifferentiated stem cells.
Maimaitili M; Chen M; Febbraro F; Ucuncu E; Kelly R; Niclis JC; Christiansen JR; Mermet-Joret N; Niculescu D; Lauritsen J; Iannielli A; Klæstrup IH; Jensen UB; Qvist P; Nabavi S; Broccoli V; Nykjær A; Romero-Ramos M; Denham M
Nat Commun; 2023 Dec; 14(1):7871. PubMed ID: 38052784
[TBL] [Abstract][Full Text] [Related]
13. Vitamin C-Induced Epigenetic Modifications in Donor NSCs Establish Midbrain Marker Expressions Critical for Cell-Based Therapy in Parkinson's Disease.
Wulansari N; Kim EH; Sulistio YA; Rhee YH; Song JJ; Lee SH
Stem Cell Reports; 2017 Oct; 9(4):1192-1206. PubMed ID: 28943252
[TBL] [Abstract][Full Text] [Related]
14. Neurogenin2 identifies a transplantable dopamine neuron precursor in the developing ventral mesencephalon.
Thompson LH; Andersson E; Jensen JB; Barraud P; Guillemot F; Parmar M; Björklund A
Exp Neurol; 2006 Mar; 198(1):183-98. PubMed ID: 16438966
[TBL] [Abstract][Full Text] [Related]
15. Brn4 and TH synergistically promote the differentiation of neural stem cells into dopaminergic neurons.
Tan X; Zhang L; Zhu H; Qin J; Tian M; Dong C; Li H; Jin G
Neurosci Lett; 2014 Jun; 571():23-8. PubMed ID: 24769320
[TBL] [Abstract][Full Text] [Related]
16. Ngn2 and Nurr1 act in synergy to induce midbrain dopaminergic neurons from expanded neural stem and progenitor cells.
Andersson EK; Irvin DK; Ahlsiö J; Parmar M
Exp Cell Res; 2007 Apr; 313(6):1172-80. PubMed ID: 17291494
[TBL] [Abstract][Full Text] [Related]
17. Expansion of human midbrain floor plate progenitors from induced pluripotent stem cells increases dopaminergic neuron differentiation potential.
Fedele S; Collo G; Behr K; Bischofberger J; Müller S; Kunath T; Christensen K; Gündner AL; Graf M; Jagasia R; Taylor V
Sci Rep; 2017 Jul; 7(1):6036. PubMed ID: 28729666
[TBL] [Abstract][Full Text] [Related]
18. Anterior-posterior graded response to Otx2 controls proliferation and differentiation of dopaminergic progenitors in the ventral mesencephalon.
Omodei D; Acampora D; Mancuso P; Prakash N; Di Giovannantonio LG; Wurst W; Simeone A
Development; 2008 Oct; 135(20):3459-70. PubMed ID: 18820178
[TBL] [Abstract][Full Text] [Related]
19. Immature Midbrain Dopaminergic Neurons Derived from Floor-Plate Method Improve Cell Transplantation Therapy Efficacy for Parkinson's Disease.
Qiu L; Liao MC; Chen AK; Wei S; Xie S; Reuveny S; Zhou ZD; Hunziker W; Tan EK; Oh SKW; Zeng L
Stem Cells Transl Med; 2017 Sep; 6(9):1803-1814. PubMed ID: 28650520
[TBL] [Abstract][Full Text] [Related]
20. Human midbrain dopaminergic neuronal differentiation markers predict cell therapy outcomes in a Parkinson's disease model.
Xu P; He H; Gao Q; Zhou Y; Wu Z; Zhang X; Sun L; Hu G; Guan Q; You Z; Zhang X; Zheng W; Xiong M; Chen Y
J Clin Invest; 2022 Jul; 132(14):. PubMed ID: 35700056
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
